LIBERO THERA
LiberoThera provides drug discovery research and development services. It focuses on making drugs with GPCRs for membrane proteins. LiberoThera was founded in 2018 and is located in Tokyo.
LIBERO THERA
Industry:
Biopharma Biotechnology Life Science Medical
Founded:
2018-04-03
Address:
Nihombashi-hamacho, Tokyo, Japan
Country:
Japan
Website Url:
http://www.liberothera.com
Total Employee:
1+
Status:
Active
Contact:
1-145-633-4725
Email Addresses:
[email protected]
Total Funding:
535 M JPY
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Font Awesome
Similar Organizations
Protai
Protai is an AI-powered drug discovery startup.
Current Employees Featured
Founder
Investors List
Miyagin Venture Capital
Miyagin Venture Capital investment in Venture Round - Libero Thera
Beyond Next Ventures
Beyond Next Ventures investment in Venture Round - Libero Thera
UTokyo Innovation Platform
UTokyo Innovation Platform investment in Venture Round - Libero Thera
MP Healthcare Venture Management
MP Healthcare Venture Management investment in Venture Round - Libero Thera
Official Site Inspections
http://www.liberothera.com
- Host name: ty10003.mixhost.jp
- IP address: 131.186.56.176
- Location: Seattle United States
- Latitude: 47.6109
- Longitude: -122.3303
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98101
More informations about "Libero Thera"
LiberoThera Co., Ltd.
We contribute to medical care through innovative . drug discovery using the technologies of cell-free . membrane protein preparation and non-canonical . amino acid incorporation into target …See details»
リベロセラ株式会社 - 無細胞膜タンパク質調製技術 お …
無細胞膜タンパク質調製技術 および 非天然型アミノ酸導入技術 を用いた革新的な創薬を通じ医療に貢献します。 - GPCRを標的とした抗体医薬を中心に創薬を行っています。See details»
Overview - LiberoThera Co., Ltd.
Jul 26, 2022 · LiberoThera Co., Ltd. Heads office: Nihonbashi Life Science Building 7, 8F 1-9-10 Nihonbashi-horidomecho, Chuo-ku, Tokyo 103-0012, JAPAN. Established: April 3, 2018. …See details»
Libero Thera - Crunchbase Company Profile & Funding
LiberoThera provides drug discovery research and development services. It focuses on making drugs with GPCRs for membrane proteins. LiberoThera was founded in 2018 and is located in …See details»
LiberoThera Co., Ltd. - VentureRadar
Website: https://www.liberothera.com/ Develops novel therapeutic candidates targeting membrane proteins using cutting-edge cell-free protein expression system and non-natural …See details»
LIBEROTHERA CO., LTD. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for LIBEROTHERA CO., LTD. of CHUO-KU, TOKYO. Get the latest business insights from Dun & …See details»
LiberoThera Company Profile 2024: Valuation, Funding …
Information on valuation, funding, cap tables, investors, and executives for LiberoThera. Use the PitchBook Platform to explore the full profile.See details»
LiberoThera, Company Limited | Portfolio | UTokyoIPC - Utokyo ...
We contribute to medical care through innovative drug discovery using the technologies of cell-free membrane protein preparation and non-canonical amino acid incorporation into target …See details»
Libero Thera - Funding, Financials, Valuation & Investors
Libero Thera is a medical care company that provides drug discovery research and development services.See details»
Business Overview - LiberoThera Co., Ltd.
Founded on revolutionary membrane protein technologies, LiberoThera has established drug discovery platform for generating quality antibodies against the challenging targets. …See details»
Libero Thera - Contacts, Employees, Board Members ... - Crunchbase
Libero Thera is a medical care company that provides drug discovery research and development services.See details»
LiberoThera Closes 535 Million JPY Financing to Develop GPCR …
Tokyo, Japan, May, 14, 2021 – LiberoThera Co., Ltd. (“LiberoThera” or the “Company”), a biotechnology company dedicated to the generation of new therapeutics targeting membrane …See details»
Biocytogen and LiberoThera Enter into Strategic Collaboration …
LiberoThera is an early-stage drug discovery company targeting GPCRs (https://www.liberothera.com/). The company was established in 2018 aiming to contribute to …See details»
Company History - LiberoThera Co., Ltd.
Japan Science and Technology Agency (JST) accepted LiberoThera’s founders’ proposal “Acceleration of novel drug development using cell-free membrane protein preparation …See details»
Biocytogen and LiberoThera Achieve Milestone Progress
Jul 21, 2022 · LiberoThera is developing novel therapeutic candidates targeting physiologically important membrane proteins, such as GPCRs, in collaboration with multiple partners. For …See details»
Biocytogen and LiberoThera Enter into Strategic Collaboration …
LiberoThera is an early-stage drug discovery company targeting GPCRs (https://www.liberothera.com/). The company was established in 2018 aiming to contribute to …See details»
Biocytogen and LiberoThera Achieve Milestone Progress in Co …
Jul 21, 2022 · LiberoThera is developing novel therapeutic candidates targeting physiologically important membrane proteins, such as GPCRs, in collaboration with multiple partners. For …See details»
News - LiberoThera Co., Ltd.
2022/07/21 LiberoThera and Biocytogen Achieve Milestone Progress in Co-Development of Fully Human GPCR Antibody Drugs ; 2022/06/01 Announced relocation of research laboratory. …See details»
Biocytogen and LiberoThera Achieve Milestone Progress in Co
Jul 21, 2022 · BEIJING & TOKYO--(BUSINESS WIRE)-- February 1 st 2021, Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen") entered a strategic collaboration with …See details»
News Release - liberothera.com
LiberoThera Closes 535 Million JPY Financing to Develop GPCR -targeting Therapeutics. Tokyo, Japan, May, 14, 2021– LiberoThera Co., Ltd. (“LiberoThera” or the “Company”), a …See details»